References
- Bartels E. C. Clinical experience with a new anti-thyroid drug: 2-carbethoxythio-l-methylglyoxaline. J. Clin. Endocrinol. 1953; 13: 13051. Bartels E. C. Clinical experience with a new anti-thyroid drug: 2-carbethoxythio-l-methylglyoxaline. J. Clin. Endocrinol. 1953; 13: 1305
- Burrell C. D., Fraser R., Doniach D. The low toxicity of caibimazole. Br. Med. J. 1956; 1: 14532. Burrell C. D., Fraser R., Doniach D. The low toxicity of caibimazole. Br. Med. J. 1956; 1: 1453
- Harrison A. R. Agranulocytosis in a patient treated with carbimazole. Lancet 1954; 1: 3963. Harrison A. R. Agranulocytosis in a patient treated with carbimazole. Lancet 1954; 1: 396
- Shaw A. B. Agranulocytosis from carbimazole. Br. Med. J. 1955; 2: 2464. Shaw A. B. Agranulocytosis from carbimazole. Br. Med. J. 1955; 2: 246